Ligand Pharmaceuticals
LGND
#3388
Rank
NZ$7.43 B
Marketcap
NZ$370.89
Share price
4.80%
Change (1 day)
109.75%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): NZ$0.27 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.26 Billion. , an increase over its 2024 earnings that were of NZ$9.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.27 B2848.57%
2024 NZ$9.45 M-91.37%
2023 NZ$0.10 B-7.59%
2022 NZ$0.11 B4%
2021 NZ$0.11 B296.42%
2020 NZ$28.75 M-97.97%
2019 NZ$1.41 B275.62%
2018 NZ$0.37 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$75.03 M55.41%
2015 NZ$48.28 M36.87%
2014 NZ$35.27 M29.59%
2013 NZ$27.22 M1309.35%
2012 NZ$1.93 M-43.97%
2011 NZ$3.44 M-113.19%
2010 -NZ$26.14 Million59.86%
2009 -NZ$16.35 Million-61.33%
2008 -NZ$42.29 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$85.05 Million81.27%
2005 -NZ$46.92 Million
2003 -NZ$32.67 Million-20.6%
2002 -NZ$41.14 Million4.38%
2001 -NZ$39.41 Million-48.83%
2000 -NZ$77.02 Million-19.74%
1999 -NZ$95.96 Million-19.06%
1998 -NZ$0.12 Billion126.71%
1997 -NZ$52.3 Million-5.83%
1996 -NZ$55.53 Million136.23%
1995 -NZ$23.51 Million-33.97%
1994 -NZ$35.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.25 B 15,772.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.03 B 6,370.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.01 B 18,916.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.47 B 5,451.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.87 Billion-410.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.40 B 7,935.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.34 B 5,763.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.05 B 6,016.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion-137.81%๐Ÿ‡บ๐Ÿ‡ธ USA